echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Renewed bids for 13 centralized procurement varieties in Wuhan, double price limit, the lowest price is planned to be selected

    Renewed bids for 13 centralized procurement varieties in Wuhan, double price limit, the lowest price is planned to be selected

    • Last Update: 2021-09-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The 13 varieties collected in Wuhan in 2019 will soon be subject to renewal bidding, with double price restriction: the quotation shall not be higher than the national lowest price and the price selected in the original quality group
    .
    The one with the lowest price will be selected and get all the pre-purchasing quantity of this quality group
    .
     
    On September 6, the Wuhan Pharmaceutical Equipment Procurement Platform issued a notice on the "Wuhan City's 2019 First Batch of Drug Centralized Procurement Contracts Expired Partial Products and Species Bidding Implementation Rules".
    , The procurement cycle is 12 months from the execution date of the selected result
    .
    The main rules are as follows:
     
    The quotation shall not be higher than the national lowest provincial-level online price of the product of the company; it shall not be higher than the price of the original selected products in the same quality group
    .
     
    Companies that do not accept the maximum price cannot enter the bidding process
    .
     
    The one with the lowest price will be selected to obtain all the pre-purchasing quantities for this quality group
    .
     
    The enterprise does not accept the non-selection of the adjusted price difference
    .
     
    The price formed by this volume purchase will not be regarded as the online price of the provincial platform
    .
     
    Previously (December 9, 2019), Wuhan City launched the first batch of drug collections in 2019, involving a total of 45 varieties, including 28 antibiotics, 5 PPIs and insulin
    .
     
    In the end, 40 of the 44 generic names (excluding insulin) were successfully purchased, and only 4 were not successful
    .
    Except Shanghai Roche did not respond, all other foreign companies responded to the bid.
    From the perspective of product regulations, more than 50% of imported varieties were shortlisted according to the decline
    .
    The national lowest price dropped by an average of 31%, and the highest price dropped by 93%
    .
     
      At that time, these varieties will be divided into two quality levels, and according to the actual sales volume in 2018, they will be divided into two groups A and B for different price reductions.
    After that, they will be diverted for gradient price reduction and quantity-the greater the price decrease, the greater the quantity; If it is exclusive, the price will be negotiated with quantity
    .
     
      It can be said that Wuhan has created a brand-new way of purchasing with quantity.
    The quality level is divided into two levels according to the "original research" and "non-original research" methods, which is unprecedented in history! And do everything possible to combine the formulations and specifications, reduce the "granularity" of recruitment, and make almost all varieties seamlessly drillable in front of the rules!
     
      On September 4 this year, the Wuhan Pharmaceutical Equipment Procurement Platform issued a notice on the revision of the "Wuhan City Drug Centralized Purchase Quality Stratification Measures" and the "Wuhan City Drug Centralized Purchase Quality Evaluation Measures", clarifying the Wuhan City Joint Procurement Office [ 2019] Document No.
    001 "Wuhan City Drug Centralized Purchase Quality Stratification Measures" and "Wuhan City Drug Centralized Purchase Quality Evaluation Measures" shall be repealed at the same time
    .
     
      However, compared with the (2009) No.
    001 document, there are more generic drugs in the first quality group in this document: passed or deemed to have passed the consistency evaluation
    .
     
      The first quality group: National Class I new drugs during the monitoring (protection) period; patented drugs within and over the protection period; generic drug reference preparations included in the "List of Listed Drugs in China"; passed or deemed to have passed the consistency evaluation Generic drugs; National proprietary Chinese medicines with confidential prescriptions; National first-class protected varieties of Chinese medicines
    .
     
      The second quality group: other GMP certified drugs and other imported drugs
    .
     
      The renewal rules pointed out that products of the first quality group can participate in the bidding as the second quality group
    .
    Let's take a look at the main content of the renewal rules
    .
     
     
      Eligibility
     
      1.
    As of May 31, 2021, all enterprise varieties that have been listed on the "Hubei Province Pharmaceutical Equipment Centralized Procurement Service Platform" can participate in the bidding
    .
     
      2.
    Enterprises that have experienced major drug quality and safety accidents, severely violated laws and regulations within three years , and are classified as dishonest enterprises are not eligible for declaration
    .
     
      3.
    Due to production companies and distribution companies, during the last implementation period, the products of companies that were unable to deliver more than 3 (times) (including 3 companies/times) on time are not eligible for declaration
    .
     
      Quotation rules
     
       (1) Enterprise quotation (including delivery fee) shall be quoted in the smallest unit of preparation, with 4 decimal places in the quotation, the currency shall be RMB, and the unit shall be yuan; the enterprise shall not modify the quotation after the quotation time expires
    .
     
       (2) The same applicant enterprise and the same bidding group can only choose one retail quantity package to participate in the quotation.
    After the shortlisted, this package is supplied in principle.
    The coefficient is multiplied together as the package purchase price (the package purchase price is rounded to 2 decimal places)
    .
     
       (3) The applying enterprise must complete the quotation and decryption by online remote decryption within the specified time, and the products that fail to decrypt successfully within the specified time and the products that the enterprise has not quoted or the quotation is "0" shall be deemed to have been abandoned
    .
     
      Quality grouping: Drug varieties are divided into the first quality group and the second quality group in accordance with the "Wuhan City Drug Purchase Quality Stratification Measures" (revised edition)
    .
    Products of the first quality group can participate in the bidding as the second quality group
    .
     
      Comprehensive scoring: Experts will comprehensively evaluate and score the varieties declared by the enterprises according to different quality groups.
    The evaluation scores of the varieties declared in the same quality group are ranked from high to low to determine the number of shortlisted companies
    .
     
     
      Varieties that meet the above rules and have the same evaluation score will enter the auction together
    .
     
      Price limit rules
     
      The expert group established the maximum price limit for each product rule based on factors such as the variety and quality grouping, the selected price in 2019, the pre-purchasing volume of medical institutions, the operation of the city's medical insurance fund, and the pre-payment of the drug fund for the purchase of drugs, including:
     
       (1) The quotation shall not be higher than the national lowest provincial-level online price for the product of the enterprise;
     
       (2) The quotation shall not be higher than the price of the original selected product specifications in the same quality group
    .
     
      Bidding method
     
       (1) Bidding procedure: The quotation is conducted through man-machine and dialogue, and the enterprise first fills in whether it accepts the maximum price
    .
    Companies that do not accept the maximum price cannot enter the bidding process
    .
    The enterprise that accepts the maximum price enters the bidding process and fills in a competitive quotation.
    The enterprise has only one opportunity to make an offer
    .
     
       (2) Winning rules: sort the effective competitive quotations of the company from low to high, the one with the lowest price will be selected, and all the pre-purchasing quantities of this quality group will be obtained; if the price is the same, the one with the highest comprehensive score will be selected; the comprehensive score is also the same The ones with high product quality scores are selected
    .
     
       (Three) other
     
      1.
    If the price difference between the same quality level, the same generic name, the same manufacturer, different dosage forms, and different specifications is large, the expert team will adjust the price of the variety according to the principle of price difference
    .
    The enterprise does not accept the non-selection of the adjusted price difference
    .
     
      2.
    If the non-selected varieties are used due to clinical needs, it shall be implemented in accordance with the filing and procurement regulations
    .
     
      3.
    The price formed by this volume purchase will not be regarded as the online price of the provincial platform
    .
     
      4.
    Enterprises that make malicious quotations or fail to guarantee supply at the selected price after being selected will be classified as dishonest behavior
    .
     
      5.
    In the procurement cycle, if you encounter a higher-level purchase with a quantity, follow the higher-level purchase policy with a quantity
    .
      The 13 varieties collected in Wuhan in 2019 will soon be subject to renewal bidding, with double price restriction: the quotation shall not be higher than the national lowest price and the price selected in the original quality group
    .
    The one with the lowest price will be selected and get all the pre-purchasing quantity of this quality group
    .
     
      On September 6, the Wuhan Pharmaceutical Equipment Procurement Platform issued a notice on the "Wuhan City's 2019 First Batch of Drug Centralized Procurement Contracts Expired Partial Products and Species Bidding Implementation Rules".
    , The procurement cycle is 12 months from the execution date of the selected result
    .
    The main rules are as follows:
     
      The quotation shall not be higher than the national lowest provincial-level online price of the product of the company; it shall not be higher than the price of the original selected products in the same quality group
    .
     
      Companies that do not accept the maximum price cannot enter the bidding process
    .
     
      The one with the lowest price will be selected to obtain all the pre-purchasing quantities for this quality group
    .
     
      The enterprise does not accept the non-selection of the adjusted price difference
    .
     
      The price formed by this volume purchase will not be regarded as the online price of the provincial platform
    .
     
      Previously (December 9, 2019), Wuhan City launched the first batch of drug collections in 2019, involving a total of 45 varieties, including 28 antibiotics, 5 PPIs and insulin
    .
     
      In the end, 40 of the 44 generic names (excluding insulin) were successfully purchased, and only 4 were not successful
    .
    Except Shanghai Roche did not respond, all other foreign companies responded to the bid.
    From the perspective of product regulations, more than 50% of imported varieties were shortlisted according to the decline
    .
    The national lowest price dropped by an average of 31%, and the highest price dropped by 93%
    .
     
      At that time, these varieties will be divided into two quality levels, and according to the actual sales volume in 2018, they will be divided into two groups A and B for different price reductions.
    After that, they will be diverted for gradient price reduction and quantity-the greater the price decrease, the greater the quantity; If it is exclusive, the price will be negotiated with quantity
    .
     
      It can be said that Wuhan has created a brand-new way of purchasing with quantity.
    The quality level is divided into two levels according to the "original research" and "non-original research" methods, which is unprecedented in history! And do everything possible to combine the formulations and specifications, reduce the "granularity" of recruitment, and make almost all varieties seamlessly drillable in front of the rules!
     
      On September 4 this year, the Wuhan Pharmaceutical Equipment Procurement Platform issued a notice on the revision of the "Wuhan City Drug Centralized Purchase Quality Stratification Measures" and the "Wuhan City Drug Centralized Purchase Quality Evaluation Measures", clarifying the Wuhan City Joint Procurement Office [ 2019] Document No.
    001 "Wuhan City Drug Centralized Purchase Quality Stratification Measures" and "Wuhan City Drug Centralized Purchase Quality Evaluation Measures" shall be repealed at the same time
    .
     
      However, compared with the (2009) No.
    001 document, there are more generic drugs in the first quality group in this document: passed or deemed to have passed the consistency evaluation
    .
     
      The first quality group: National Class I new drugs during the monitoring (protection) period; patented drugs within and over the protection period; generic drug reference preparations included in the "List of Listed Drugs in China"; passed or deemed to have passed the consistency evaluation Generic drugs; National proprietary Chinese medicines with confidential prescriptions; National first-class protected varieties of Chinese medicines
    .
     
      The second quality group: other GMP certified drugs and other imported drugs
    .
     
      The renewal rules pointed out that products of the first quality group can participate in the bidding as the second quality group
    .
    Let's take a look at the main content of the renewal rules
    .
     
     
      Eligibility
     
      1.
    As of May 31, 2021, all enterprise varieties that have been listed on the "Hubei Province Pharmaceutical Equipment Centralized Procurement Service Platform" can participate in the bidding
    .
     
      2.
    Enterprises that have experienced major drug quality and safety accidents, severely violated laws and regulations within three years , and are classified as dishonest enterprises are not eligible for declaration
    .
     
      3.
    Due to production companies and distribution companies, during the last implementation period, the products of companies that were unable to deliver more than 3 (times) (including 3 companies/times) on time are not eligible for declaration
    .
     
      Quotation rules
     
       (1) Enterprise quotation (including delivery fee) shall be quoted in the smallest unit of preparation, with 4 decimal places in the quotation, the currency shall be RMB, and the unit shall be yuan; the enterprise shall not modify the quotation after the quotation time expires
    .
     
       (2) The same applicant enterprise and the same bidding group can only choose one retail quantity package to participate in the quotation.
    After the shortlisted, this package is supplied in principle.
    The coefficient is multiplied together as the package purchase price (the package purchase price is rounded to 2 decimal places)
    .
     
       (3) The applying enterprise must complete the quotation and decryption by online remote decryption within the specified time, and the products that fail to decrypt successfully within the specified time and the products that the enterprise has not quoted or the quotation is "0" shall be deemed to have been abandoned
    .
     
      Quality grouping: Drug varieties are divided into the first quality group and the second quality group in accordance with the "Wuhan City Drug Purchase Quality Stratification Measures" (revised edition)
    .
    Products of the first quality group can participate in the bidding as the second quality group
    .
     
      Comprehensive scoring: Experts will comprehensively evaluate and score the varieties declared by the enterprises according to different quality groups.
    The evaluation scores of the varieties declared in the same quality group are ranked from high to low to determine the number of shortlisted companies
    .
     
     
      Varieties that meet the above rules and have the same evaluation score will enter the auction together
    .
     
      Price limit rules
     
      The expert group established the maximum price limit for each product rule based on factors such as the variety and quality grouping, the selected price in 2019, the pre-purchasing volume of medical institutions, the operation of the city's medical insurance fund, and the pre-payment of the drug fund for the purchase of drugs, including:
     
       (1) The quotation shall not be higher than the national lowest provincial-level online price for the product of the enterprise;
     
       (2) The quotation shall not be higher than the price of the original selected product specifications in the same quality group
    .
     
      Bidding method
     
       (1) Bidding procedure: The quotation is conducted through man-machine and dialogue, and the enterprise first fills in whether it accepts the maximum price
    .
    Companies that do not accept the maximum price cannot enter the bidding process
    .
    The enterprise that accepts the maximum price enters the bidding process and fills in a competitive quotation.
    The enterprise has only one opportunity to make an offer
    .
     
       (2) Winning rules: sort the effective competitive quotations of the company from low to high, the one with the lowest price will be selected, and all the pre-purchasing quantities of this quality group will be obtained; if the price is the same, the one with the highest comprehensive score will be selected; the comprehensive score is also the same The ones with high product quality scores are selected
    .
     
       (Three) other
     
      1.
    If the price difference between the same quality level, the same generic name, the same manufacturer, different dosage forms, and different specifications is large, the expert team will adjust the price of the variety according to the principle of price difference
    .
    The enterprise does not accept the non-selection of the adjusted price difference
    .
     
      2.
    If the non-selected varieties are used due to clinical needs, it shall be implemented in accordance with the filing and procurement regulations
    .
     
      3.
    The price formed by this volume purchase will not be regarded as the online price of the provincial platform
    .
     
      4.
    Enterprises that make malicious quotations or fail to guarantee supply at the selected price after being selected will be classified as dishonest behavior
    .
     
      5.
    In the procurement cycle, if you encounter a higher-level purchase with a quantity, follow the higher-level purchase policy with a quantity
    .
      The 13 varieties collected in Wuhan in 2019 will soon be subject to renewal bidding, with double price restriction: the quotation shall not be higher than the national lowest price and the price selected in the original quality group
    .
    The one with the lowest price will be selected and get all the pre-purchasing quantity of this quality group
    .
     
      On September 6, the Wuhan Pharmaceutical Equipment Procurement Platform issued a notice on the "Wuhan City's 2019 First Batch of Drug Centralized Procurement Contracts Expired Partial Products and Species Bidding Implementation Rules".
    , The procurement cycle is 12 months from the execution date of the selected result
    .
    The main rules are as follows:
     
      The quotation shall not be higher than the national lowest provincial-level online price of the product of the company; it shall not be higher than the price of the original selected products in the same quality group
    .
     
      Companies that do not accept the maximum price cannot enter the bidding process
    .
     
      The one with the lowest price will be selected to obtain all the pre-purchasing quantities for this quality group
    .
     
      The enterprise does not accept the non-selection of the adjusted price difference
    .
     
      The price formed by this volume purchase will not be regarded as the online price of the provincial platform
    .
     
      Previously (December 9, 2019), Wuhan City launched the first batch of drug collections in 2019, involving a total of 45 varieties, including 28 antibiotics, 5 PPIs and insulin
    .
     
      In the end, 40 of the 44 generic names (excluding insulin) were successfully purchased, and only 4 were not successful
    .
    Except Shanghai Roche did not respond, all other foreign companies responded to the bid.
    From the perspective of product regulations, more than 50% of imported varieties were shortlisted according to the decline
    .
    The national lowest price dropped by an average of 31%, and the highest price dropped by 93%
    .
     
      At that time, these varieties will be divided into two quality levels, and according to the actual sales volume in 2018, they will be divided into two groups A and B for different price reductions.
    After that, they will be diverted for gradient price reduction and quantity-the greater the price decrease, the greater the quantity; If it is exclusive, the price will be negotiated with quantity
    .
     
      It can be said that Wuhan has created a brand-new way of purchasing with quantity.
    The quality level is divided into two levels according to the "original research" and "non-original research" methods, which is unprecedented in history! And do everything possible to combine the formulations and specifications, reduce the "granularity" of recruitment, and make almost all varieties seamlessly drillable in front of the rules!
     
      On September 4 this year, the Wuhan Pharmaceutical Equipment Procurement Platform issued a notice on the revision of the "Wuhan City Drug Centralized Purchase Quality Stratification Measures" and the "Wuhan City Drug Centralized Purchase Quality Evaluation Measures", clarifying the Wuhan City Joint Procurement Office [ 2019] Document No.
    001 "Wuhan City Drug Centralized Purchase Quality Stratification Measures" and "Wuhan City Drug Centralized Purchase Quality Evaluation Measures" shall be repealed at the same time
    .
     
      However, compared with the (2009) No.
    001 document, there are more generic drugs in the first quality group in this document: passed or deemed to have passed the consistency evaluation
    .
     
      The first quality group: National Class I new drugs during the monitoring (protection) period; patented drugs within and over the protection period; generic drug reference preparations included in the "List of Listed Drugs in China"; passed or deemed to have passed the consistency evaluation Generic drugs; National proprietary Chinese medicines with confidential prescriptions; National first-class protected varieties of Chinese medicines
    .
     
      The second quality group: other GMP certified drugs and other imported drugs
    .
     
      The renewal rules pointed out that products of the first quality group can participate in the bidding as the second quality group
    .
    Let's take a look at the main content of the renewal rules
    .
     
     
      Eligibility
      Eligibility
     
      1.
    As of May 31, 2021, all enterprise varieties that have been listed on the "Hubei Province Pharmaceutical Equipment Centralized Procurement Service Platform" can participate in the bidding
    .
     
      2.
    Enterprises that have experienced major drug quality and safety accidents, severely violated laws and regulations within three years , and are classified as dishonest enterprises are not eligible for declaration
    .
    Drugs Drugs and Drug Regulations Regulations Regulations enterprise business enterprise
     
      3.
    Due to production companies and distribution companies, during the last implementation period, the products of companies that were unable to deliver more than 3 (times) (including 3 companies/times) on time are not eligible for declaration
    .
     
      Quotation rules
      Quotation rules
     
       (1) Enterprise quotation (including delivery fee) shall be quoted in the smallest unit of preparation, with 4 decimal places in the quotation, the currency shall be RMB, and the unit shall be yuan; the enterprise shall not modify the quotation after the quotation time expires
    .
     
       (2) The same applicant enterprise and the same bidding group can only choose one retail quantity package to participate in the quotation.
    After the shortlisted, this package is supplied in principle.
    The coefficient is multiplied together as the package purchase price (the package purchase price is rounded to 2 decimal places)
    .
     
       (3) The applying enterprise must complete the quotation and decryption by online remote decryption within the specified time, and the products that fail to decrypt successfully within the specified time and the products that the enterprise has not quoted or the quotation is "0" shall be deemed to have been abandoned
    .
     
      Quality grouping: Drug varieties are divided into the first quality group and the second quality group in accordance with the "Wuhan City Drug Purchase Quality Stratification Measures" (revised edition)
    .
    Products of the first quality group can participate in the bidding as the second quality group
    .
     
      Comprehensive scoring: Experts will comprehensively evaluate and score the varieties declared by the enterprises according to different quality groups.
    The evaluation scores of the varieties declared in the same quality group are ranked from high to low to determine the number of shortlisted companies
    .
     
     
      Varieties that meet the above rules and have the same evaluation score will enter the auction together
    .
     
      Price limit rules
      Price limit rules
     
      The expert group established the maximum price limit for each product rule based on factors such as the variety and quality grouping, the selected price in 2019, the pre-purchasing volume of medical institutions, the operation of the city's medical insurance fund, and the pre-payment of the drug fund for the purchase of drugs, including:
     
       (1) The quotation shall not be higher than the national lowest provincial-level online price for the product of the enterprise;
     
       (2) The quotation shall not be higher than the price of the original selected product specifications in the same quality group
    .
     
      Bidding method
      Bidding method
     
       (1) Bidding procedure: The quotation is conducted through man-machine and dialogue, and the enterprise first fills in whether it accepts the maximum price
    .
    Companies that do not accept the maximum price cannot enter the bidding process
    .
    The enterprise that accepts the maximum price enters the bidding process and fills in a competitive quotation.
    The enterprise has only one opportunity to make an offer
    .
     
       (2) Winning rules: sort the effective competitive quotations of the company from low to high, the one with the lowest price will be selected, and all the pre-purchasing quantities of this quality group will be obtained; if the price is the same, the one with the highest comprehensive score will be selected; the comprehensive score is also the same The ones with high product quality scores are selected
    .
    Product quality product quality product quality
     
       (Three) other
       (Three) other
     
      1.
    If the price difference between the same quality level, the same generic name, the same manufacturer, different dosage forms, and different specifications is large, the expert team will adjust the price of the variety according to the principle of price difference
    .
    The enterprise does not accept the non-selection of the adjusted price difference
    .
     
      2.
    If the non-selected varieties are used due to clinical needs, it shall be implemented in accordance with the filing and procurement regulations
    .
    Procurement Procurement Procurement
     
      3.
    The price formed by this volume purchase will not be regarded as the online price of the provincial platform
    .
     
      4.
    Enterprises that make malicious quotations or fail to guarantee supply at the selected price after being selected will be classified as dishonest behavior
    .
     
      5.
    In the procurement cycle, if you encounter a higher-level purchase with a quantity, follow the higher-level purchase policy with a quantity
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.